Cantitate/Preț
Produs

SGLT-2 Inhibitors, An Issue of Heart Failure Clinics: The Clinics: Internal Medicine, cartea 18-4

Editat de Deepak L. Bhatt, Ragavendra R. Baliga
en Limba Engleză Hardback – 10 oct 2022
In this issue, guest editors bring their considerable expertise to this important topic.
Citește tot Restrânge

Din seria The Clinics: Internal Medicine

Preț: 43230 lei

Preț vechi: 45505 lei
-5% Nou

Puncte Express: 648

Preț estimativ în valută:
8275 8687$ 6835£

Carte tipărită la comandă

Livrare economică 24 ianuarie-07 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780323960465
ISBN-10: 0323960464
Pagini: 240
Dimensiuni: 178 x 254 mm
Greutate: 0.54 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine


Cuprins

Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors
Renoprotective Effects of SGLT2 Inhibitors
SGLT2 Inhibitors in Type 2 Diabetes Mellitus
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: A Paradigm Shift Toward Dual Cardio-Renal Protection
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction
SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events
SGLT2 Inhibitors and Peripheral Vascular Events: A Review of the Literature
Sodium-glucose Cotransporter 2 Inhibitors and Nonalcoholic Fatty Liver Disease
SGLT2 Inhibitors and Safety in Older Patients
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk